Active Ingredient: NELARABINE
Proprietary Name: NELARABINE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 250MG/50ML (5MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A215057
Product Number: 001
Approval Date: Jun 2, 2023
Applicant Holder Full Name: NEXUS PHARMACEUTICALS LLC
Marketing Status:
Prescription
Patent and Exclusivity Information